![](https://lymphoma.org/wp-content/uploads/2017/06/News_FDAUpdate.jpg.webp)
U.S. Food and Drug Administration Requests Voluntary Recall of Textured Implants Linked to Breast Implant-Associated Anaplastic Large Cell Lymphoma
The U.S. Food and Drug Administration (FDA) requested the voluntary recall from Allergan in reference to the company’s Biocell textured implants linked to breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). According to the Agency, Allergan agreed and is removing these…